Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 7,830.00
-370.00 (-4.51%)
Oct 12, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 724.29 billion as of October 12, 2026. It is the 14,201st most valuable company in the world and the 366th biggest in South Korea. Its market cap has decreased by 15.09% in one year.
Market Cap
724.29B
Enterprise Value
1.79T
Revenue
1.31T
Global Rank
Country Rank
#366 South Korea
PE Ratio
50.75
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 724.29B, an increase of 116.77%. That is a compound annual growth rate of 4.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 724.29B | -35.30% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.36T |
| Komipharm International | 821.80B |
| Pharmicell | 771.65B |
| Onconic Therapeutics | 675.21B |
| Hyundai Bioscience | 668.77B |
| GI Innovation | 545.81B |
| AbClon | 509.78B |
| Proteina | 489.96B |